Cite
HARVARD Citation
Manders, S. et al. (2014). SAT0253 Cost-Effectiveness of Abatacept, Rituximab or A TNFI after Failure of the First TNFI Treatment in RA: Results of A Multi-Centered Pragmatic RCT in the DREAM Registry. Annals of the rheumatic diseases. p. 684. [Online].